What Is Trigeminal Neuralgia in MS All About, Anyway?
My immediate thought after reading a recent MS News Today headline stating that trigeminal neuralgia (TN) affects more than…
Articles by Ed Tobias
MS News That Caught My Eye Last Week: Predicting Disease Progression, Temelimab, Trigeminal Neuralgia
Combined Data May Predict Person’s Risk of Advancing From CIS to MS Clinically isolated syndrome is sometimes…
Taking Another Look at Vitamin D, Immune Tolerance, and MS
I’ve been popping vitamin D pills for years — decades, really. I never really understood why, I just knew that…
MS News That Caught My Eye Last Week: COVID-19 Booster, EBV Treatment, Childhood MS Risks, Vitamin D
COVID-19 Booster May Benefit Patients on Anti-CD20 Therapy After multiple reports of how Gilenya and anti-CD20 MS medications reduce…
MS Hiker Laces Up Her Boots for Appalachian Trail
Reservations at a base lodge have been made, and a starting date is circled on her calendar. MS hiker April…
MS News That Caught My Eye Last Week: MRSI, Acthar Gel, Tecfidera vs. Gilenya, Exergames
Imaging Brain Metabolites May Help Diagnose, Monitor MS Have you ever heard of magnetic resonance spectroscopic imaging, or MRSI?…
An Epstein-Barr Virus Primer for MS Patients
You may have heard about the research that’s just been published about the Epstein-Barr virus (EBV) and multiple sclerosis…
MS News That Caught My Eye Last Week: Epstein-Barr Virus, EHP-101, Anti-CD20 Therapies, Gut Bacteria
Epstein-Barr Virus May be Leading Cause of MS, Raising Risk by 32 Times Several studies over the past few…
Aquatic Therapy for Chronic Back Pain
Multiple sclerosis (MS) has gotten to be a real pain in the back. In the past couple years, I’ve developed…
MS News That Caught My Eye Last Week: Lemtrada, Music and White Matter, Diagnosing MS
AB Science OK’d to Start Masitinib Phase 3 Trial for Progressive MS Many of us with multiple sclerosis (MS)…
More Answers About COVID-19 Vaccines and MS
A little over a year ago, I wrote about whether people with multiple sclerosis (MS) should get a COVID-19…
MS News That Caught My Eye Last Week: Cortrophin Gel, Simvastatin, COVID-19 Treatments
Cortrophin Gel Now Available in US at AllianceRx Walgreens Prime Cortrophin Gel is similar to Achtar Gel, which was,…
MS News That Caught My Eye Last Week: COVID-19 Vaccines, Achtar Gel, Ublituximab, Pregnancy
Study: Anti-CD20 Therapies, Gilenya Lower Efficacy of COVID-19 Vaccines This research adds more evidence to studies that have already…
Sun-seeking Finds Support in New Study
I’m back in Florida for the next several months, having left cloudy, windy, chilly Maryland for the Gulf Coast. It’s…
MS News That Caught My Eye Last Week: DMTs and Age, Lyvispah, Cells Driving MS, Melatonin
Worsening of Disability Evident in Older Patients Who Stop DMTs Some neurologists believe that multiple sclerosis (MS) progression slows,…
I’m Back on the MS ‘Bladder Coaster’
I thought I finally had this bladder thing licked. After years of urinary urgency and frequency, I’d been doing…
MS News That Caught My Eye Last Week: Vitamin D Deficiency, Emotions, Neurostimulation
Vitamin D Deficiency Linked to Early Cognitive Issues in Study I’ve taken a vitamin D supplement for many years…
My Lemtrada Treatment, 5 Years Later
It was five years ago, Dec. 5, 2016, that I scootered into the office of Dr. Heidi Crayton, my neurologist,…
MS News That Caught My Eye Last Week: Stem Cell Trial, COVID-19 Vaccines, MS Blood Test
First Patient Dosed in Phase 1 Trial of IMS001 Therapy IMS001 is an investigational treatment that uses mesenchymal stem…
MS News That Caught My Eye Last Week: Neural Sleeve, Supplements, Ocrevus, Cladribine Injection
Wearable ‘Neural Sleeve’ Counters Foot Drop, Aids Mobility in Study This is a neat concept, described by the manufacturer…
Can Focusing on the Epstein-Barr Virus Help Researchers Fight MS?
There are continuing signals that the Epstein-Barr virus (EBV) is a fuel that can spark a multiple sclerosis (MS) fire.
MS News That Caught My Eye Last Week: NVG-291, Ocrevus, Tolebrutinib, Tecfidera
Nerve Repair Therapy NVG-291 Safe, Well-tolerated in Healthy People This experimental therapy has a long way to go before…
I’m Sleeping Better These Days, but Why?
I had a great night’s sleep the other night. I fell asleep quickly and slept straight through the night for…
MS News That Caught My Eye Last Week: Acthar Gel, Alcohol and MS Risk, Mindfulness
Analysis Finds Acthar Gel Cost-effective for MS Relapses I’ve seen social media posts from people with MS who use…
I’m Grateful for My COVID-19 Booster Shot
I’m hurtin’ a little today. I have mild muscle aches, a bit more fatigue than usual, and dragging legs. It…
MS News That Caught My Eye Last Week: Mono and MS, Cold and Inflammation, Mesenchymal Stem Cells, MS Smartwatch
Mono as Child or Teenager Tied to Risk of MS as Adult in Large Study There’s been a lot…
Researchers Lower the Temperature to Try to Reduce MS Inflammation
I hate the cold. It triggers my bladder and stiffens my legs. When the leaves start to turn in…
MS News That Caught My Eye Last Week: AHSCT, Ocrevus, CD20 T-cells, Spasticity App
National MS Society Supports Stem Cell Transplant for Select, Aggressive RRMS Bravo! This statement is welcome after the recommendation…
It’s Flu Vaccine Time Again, So Here’s What You Need to Know
A couple weeks ago, my wife and I rolled up our sleeves and got our shots again. No, not the…
MS News That Caught My Eye Last Week: AHSCT for SPMS, Rituximab, Sativex, Smoking
This week’s column focuses on stories from Multiple Sclerosis News Today reporters who have been following the annual Congress…